Jiefeng G. He

Taiyuan, 030032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Functional characterization of triokinase/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma.

Functional characterization of triokinase/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma.

Journal: International journal of biological macromolecules

Published: January 24, 2026

Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling.

Loganin Ameliorates Cholestatic Liver Fibrosis by Inhibiting Hepatic Stellate Cell Autophagy and Activation Through EGFR Signaling.

Journal: Mediators of inflammation

Published: May 21, 2025

Research advancements regarding the relationship between FBXO2 and malignant tumors (Review).

Research advancements regarding the relationship between FBXO2 and malignant tumors (Review).

Journal: Molecular medicine reports

Published: March 16, 2025

PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review).

PPM1G and its diagnostic, prognostic and therapeutic potential in HCC (Review).

Journal: International journal of oncology

Published: May 31, 2024

M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-βcatenin/Hippo pathway.

M6A modification-mediated LIMA1 promotes the progression of hepatocellular carcinoma through the wnt-βcatenin/Hippo pathway.

Journal: Cell biology and toxicology

Published: May 06, 2024

The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms.

The emerging roles of circHECTD1 in human diseases and the specific underlying regulatory mechanisms.

Journal: PeerJ

Published: February 16, 2024

Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.

Targeting N4-acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2-mediated HMGB2 mRNA translation.

Journal: Cancer communications (London, England)

Published: February 06, 2024

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).

Chinese Expert Consensus on the Whole-Course Management of Hepatocellular Carcinoma (2023 Edition).

Journal: Liver cancer

Published: January 31, 2024

CircWHSC1 (CircNSD2): A Novel Circular RNA in Multiple Cancers.

CircWHSC1 (CircNSD2): A Novel Circular RNA in Multiple Cancers.

Journal: Clinical Medicine Insights. Oncology

Published: November 01, 2023

Long non-coding RNA LINC01554 overexpression suppresses viability, migration, and invasion of liver cancer cells through regulating miR-148b-3p/EIF4E3.

Long non-coding RNA LINC01554 overexpression suppresses viability, migration, and invasion of liver cancer cells through regulating miR-148b-3p/EIF4E3.

Journal: Heliyon

Published: September 05, 2023

Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.

Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 02, 2023

The Functional Mechanisms of Toll-Like Receptor 3 and Its Implications in Digestive System Tumors.

The Functional Mechanisms of Toll-Like Receptor 3 and Its Implications in Digestive System Tumors.

Journal: Frontiers in bioscience (Landmark edition)

Published: April 30, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026